Skip to main content

Kailera Therapeutics, Inc.

For the period ended Mar 31, 2026. Filed May 26, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 26, 2026

KLRA$12.97+6.6%Stored close · as of Nov 6, 2026
Opening this filing…